Related Experiment Video
Updated: Nov 9, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Key biomarkers within the colorectal cancer related inflammatory microenvironment
Valentin Calu1,2, Adriana Ionescu3, Loredana Stanca4
1Department of General Surgery, University of Medicine and Pharmacy "Carol Davila" Bucharest, 8 Blvd., Eroii Sanitari, 050474, Bucharest, Romania.
Abstract:
Therapeutic approaches focused on the inflammatory microenvironment are currently gaining more support, as biomolecules involved in the inflammatory colorectal cancer (CRC) tumor microenvironment are being explored. We analyzed tumor and paired normal tissue samples from CRC patients (n = 22) whom underwent tumor resection surgery. We assessed 39 inflammation-involved biomolecules (multiplex magnetic bead-based immunoassay), CEA and CA19-9 (ELISA assay) and the tissue expression levels of occludin and also pErk, STAT1 and STAT3 transcriptional factors (western blot). Tumor staging has been established by histopathological evaluation of HE stained tumor tissue sections. We report 32 biomarkers displaying statistically significant differences in tumor vs. control. Additionally, positive statistical biomarker correlations were found between MMP2-IL8 and BAFF-IL8 (Pearson correlation coefficients > 0.751), while APRIL-MMP2, APRIL-BAFF and APRIL-IL8 were negatively correlated (correlation coefficients < - 0.650). While APRIL, BAFF, IL8 and MMP2 did not modulate with tumor stage, they were inversely related to the immune infiltrate level and CD163 tissue expression. We conclude that the significantly decreased APRIL and increased BAFF, IL8 and MMP2 expression were tumor-specific and deserve consideration in the development of new treatments. Also, the positive correlation between Chitinase 3-like 1 and IL8 (0.57) or MMP2 (0.50) suggest a role in tumor growth and metastasis pathways.
Insights
Researchers identified key inflammation biomarkers in colorectal cancer (CRC) tissues. Decreased APRIL and increased BAFF, IL8, and MMP2 levels were tumor-specific, offering potential therapeutic targets for CRC.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- The tumor microenvironment's inflammatory aspects are crucial in colorectal cancer (CRC) progression.
- Understanding specific biomolecules involved can lead to novel therapeutic strategies.
Purpose of the Study:
- To analyze and identify inflammation-associated biomolecules in CRC tumor tissues compared to normal tissues.
- To explore correlations between these biomolecules, tumor stage, and immune infiltrate.
Main Methods:
- Analysis of tumor and normal tissues from 22 CRC patients.
- Multiplex immunoassay for 39 inflammation biomarkers.
- ELISA for CEA and CA19-9.
- Western blot for occludin, pErk, STAT1, and STAT3.
- Histopathological evaluation for tumor staging.
Main Results:
- 32 biomarkers showed significant differences between tumor and normal tissues.
- Positive correlations found between MMP2-IL8 and BAFF-IL8.
- Negative correlations observed for APRIL with MMP2, BAFF, and IL8.
- APRIL, BAFF, IL8, and MMP2 levels inversely correlated with immune infiltrate and CD163 expression, independent of tumor stage.
Conclusions:
- Significantly decreased APRIL and increased BAFF, IL8, and MMP2 expression are tumor-specific in CRC.
- These specific biomarkers warrant further investigation for developing new CRC treatments.
- Correlations suggest roles for Chitinase 3-like 1, IL8, and MMP2 in tumor growth and metastasis.
More Related Videos
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Related Concept Videos
The Tumor Microenvironment
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...